AJP - Heart Myographs and Tissue organ baths
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 291: H1653-H1658, 2006. First published May 12, 2006; doi:10.1152/ajpheart.00363.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/H1653    most recent
00363.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Morgan, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Morgan, J. P.

Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells

Yu Chen,1,2,* Ivo Amende,1,* Thomas G. Hampton,1 Yinke Yang,1 Qingen Ke,1 Jiang-Yong Min,1 Yong-Fu Xiao,1 and James P. Morgan1,3

1Cardiovascular Division, Department of Medicine, the Charles A. Dana Research Institute and Harvard-Thorndike Laboratories, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; 2Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York; and 3Division of Cardiovascular Medicine, Caritas St. Elizabeth's Medical Center, Boston, Massachusetts

Submitted 12 April 2005 ; accepted in final form 3 May 2006

Embryonic stem cells (ESCs) overexpressing the vascular endothelial growth factor (VEGF) improve cardiac function in mouse models of myocardial ischemia and infarction by mechanisms that are poorly understood. Here we studied the effects of VEGF on cardiomyocyte differentiation of mouse ESCs in vitro. We used flow cytometry to determine the expression of {alpha}-myosin heavy chain ({alpha}-MHC), cardiac troponin I (cTn-I), and Nkx2.5 in differentiated ESCs. VEGF (20 ng/ml) significantly enhanced {alpha}-MHC, cTn-I, and Nkx2.5 expression in differentiated ESCs. Western blot analysis confirmed these findings. We found that VEGF receptor FMS-like tyrosine kinase-1 (Flt-1) and fetal liver kinase-1 (Flk-1) expression increased during ESC differentiation. Antibodies against Flk-1 totally blocked and against Flt-1 partially blocked VEGF-induced NKx2.5-positive-stained cells. The ERK inhibitor PD-098059 abolished VEGF-induced cardiomyocyte differentiation of ESCs. Our results suggest that VEGF promotes cardiomyocyte differentiation predominantly by ERK-mediated Flk-1 activation and, to a lesser extent, by Flt-1 activation. These findings may be of significance for stem cell and growth factor therapies to regenerate failing cardiomyocytes.

cardiac-specific proteins; Flt-1 and Flk-1; extracellular signal-regulated kinase


Address for reprint requests and other correspondence: J. P. Morgan, Harvard Medical School, Boston, MA 02215 (E-mail: james.morgan{at}caritaschristi.org)




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
K.-D. Schluter, R. Schreckenberg, and S. Wenzel
Stem cell mobilization versus stem cell homing: potential role for parathyroid hormone?
Cardiovasc Res, March 1, 2008; 77(4): 612 - 613.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.